Abstract
Purpose: To evaluate the effectiveness of complex treatment included the eyelid hygiene in non-infectious chronic blepharitis patients. Methods: 50 non-infectious chronic blepharitis, meibomian gland dysfunction and dry eye patients (18‑46 years) were examined before and after the treatment (eyelid hygiene using Blepharoshampoo, Blepharolotion or Blepharosalfetka, Blepharogel-1; anti-inflammatory therapy; artificial tears). Traditional ophthalmological examination, consideration of subjective discomfort level, evaluation of meibomian gland function (compression test) and severity of eyelid epitheliopaty (lyssamine green staining), lipid-interferential test, Schirmer’s test, tear film break up time, optical coherent meniscometry, computer evaluation of xerosis indicator (lyssamine green staining) and ocular surface microbiological examination were performed in all the patients. Results : Positive therapeutic effect was noted in all of the observed. It included the following significant changes: reducing the level of subjective discomfort; decreasing of sins of eyelid inflammation; increasing of meibomian gland function; improvement of tear film and ocular surface tissues. Conclusion: Complex treatment, including eyelid hygiene (using Blepharoshampoo, Blepharolotion or Blepharosalfetka, Blepharogel-1), antiinflammatory therapy and artificial tears, allows achieving significant reduction of subjective symptoms and both functional and objective signs of the disease in non-infectious chronic blepharitis patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.